Phase 2 Metastatic Non-Squamous Non-Small Cell Lung Cancer Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor

CatalYm GmbH131 enrolled15 locationsNCT07246863

Recruiting

Phase 2

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor

CatalYm GmbH107 enrolled25 locationsNCT07098988